Publicité
Publicité

AIM

AIM logo

AIM ImmunoTech Inc.

1.28
USD
Sponsorisé
-0.06
-4.38%
09 janv., 15:56 UTC -5
Fermé
exchange

Après-marché

1.31

+0.03
+2.27%

AIM Rapports sur les bénéfices

Ratio de surprise positive

AIM a dépassé 14 des 29 dernières estimations.

48%

Prochain rapport

Date du prochain rapport
30 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.97
Variation implicite de Q3 25 (Revenue/ EPS)
-100.00%
/
-38.22%
Variation implicite de Q4 24 (Revenue/ EPS)
-100.00%
/
-90.30%

AIM ImmunoTech Inc. earnings per share and revenue

On 17 nov. 2025, AIM reported earnings of -1.57 USD per share (EPS) for Q3 25, missing the estimate of -0.98 USD, resulting in a -59.42% surprise. Revenue reached 26.00 mille, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.97 USD, with revenue projected to reach -- USD, implying an baisse of -38.22% EPS, and baisse of -100.00% in Revenue from the last quarter.
FAQ
For Q3 2025, AIM ImmunoTech Inc. reported EPS of -$1.57, missing estimates by -59.42%, and revenue of $26.00K, 0% as expectations.
The stock price moved down -7.64%, changed from $1.44 before the earnings release to $1.33 the day after.
The next earning report is scheduled for 30 mars 2026.
Based on 3 analystes, AIM ImmunoTech Inc. is expected to report EPS of -$0.97 and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité